Provides an update on the status of biosimilars and a perspective for the next decade. How biosimilars are developed in the future will include many AI-based features to establish structural similarity that will prevent the need for most other testing, including detailed analytical assessment and clinical pharmacology testing.
juillet 2024, env. 188 pages, Anglais
Taylor and Francis
978-1-03-251701-8
Taylor and Francis
978-1-03-251701-8